3.98
price down icon1.73%   -0.07
after-market アフターアワーズ: 3.80 -0.18 -4.52%
loading
前日終値:
$4.05
開ける:
$4.03
24時間の取引高:
289.42K
Relative Volume:
1.86
時価総額:
$42.98M
収益:
-
当期純損益:
$-19.25M
株価収益率:
-2.236
EPS:
-1.78
ネットキャッシュフロー:
$-17.87M
1週間 パフォーマンス:
+0.13%
1か月 パフォーマンス:
-10.66%
6か月 パフォーマンス:
+15.36%
1年 パフォーマンス:
+8.74%
1日の値動き範囲:
Value
$3.80
$4.11
1週間の範囲:
Value
$3.70
$4.34
52週間の値動き範囲:
Value
$2.55
$6.118

Lantern Pharma Inc Stock (LTRN) Company Profile

Name
名前
Lantern Pharma Inc
Name
セクター
Healthcare (1135)
Name
電話
972-277-1136
Name
住所
1920 MCKINNEY AVENUE, DALLAS, TX
Name
職員
24
Name
Twitter
@lanternpharma
Name
次回の収益日
2025-08-08
Name
最新のSEC提出書
Name
LTRN's Discussions on Twitter

LTRN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LTRN
Lantern Pharma Inc
3.98 43.74M 0 -19.25M -17.87M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.39 107.73B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
654.48 62.04B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
475.91 62.73B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
836.39 51.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.29 34.67B 398.11M -1.03B -868.57M -5.7032

Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-10-07 開始されました H.C. Wainwright Buy

Lantern Pharma Inc (LTRN) 最新ニュース

pulisher
12:33 PM

Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers. - BioSpace

12:33 PM
pulisher
Oct 28, 2025

Lantern Pharma (NASDAQ: LTRN) Reports Complete Metabolic Response in Phase 1 LP-284 Trial at LL&M Congress - Digital Journal

Oct 28, 2025
pulisher
Oct 28, 2025

Will Lantern Pharma Inc. stock recover after recent dropWeekly Risk Report & Growth-Oriented Investment Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Using economic indicators to assess Lantern Pharma Inc. potentialIPO Watch & Target Return Focused Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Lantern Pharma (LTRN) Reports Promising Phase 1 Trial Results for LP-284 - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Lantern Pharma presents LP-284 clinical data at 25th LL&M Congress - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Is Lantern Pharma Inc. stock attractive for income investorsInsider Selling & Weekly Return Optimization Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What technical signals suggest for Lantern Pharma Inc. stockGDP Growth & Growth Focused Stock Pick Reports - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Is Lantern Pharma Inc. stock a buy before product launchesTrade Volume Summary & Advanced Technical Analysis Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Lantern Pharma Inc. stock trendline breakdown2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Lantern Pharma Inc. stock maintain dividend yieldQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Why Lantern Pharma Inc. stock is favored by pension fundsTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma’s LP-284 Study: A Potential Game-Changer in Cancer Treatment? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma’s LP-184 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

When is the best time to exit Lantern Pharma Inc.July 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025 - BioSpace

Oct 27, 2025
pulisher
Oct 26, 2025

How to interpret RSI for Lantern Pharma Inc. stock2025 Macro Impact & AI Forecasted Stock Moves - newser.com

Oct 26, 2025

Lantern Pharma Inc (LTRN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.41
price down icon 2.28%
$91.65
price down icon 1.54%
$29.13
price up icon 0.34%
$105.03
price down icon 0.96%
biotechnology ONC
$316.85
price up icon 0.45%
$165.29
price up icon 0.77%
大文字化:     |  ボリューム (24 時間):